SEC Filings

Form 8-K
BEIGENE, LTD. filed this Form 8-K on 08/03/2018
Document Outline
Entire Document (623.1 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01 Entry into a Material Definitive Agreement.
Page 3 - Item 9.01 Financial Statements and Exhibits.
Page 4 - Exhibit Index
Page 5 - SIGNATURES
Subdocument 2 - EX-1.1 - EX-1.1
Page 1 - Exhibit 1.1
Page 2 - MSIP )
Page 3 - Company ), proposes to issue and sell to the purchasers procured by the several International Underw
Page 4 - Joint Global Coordinators ) of the Global Offering.
Page 5 - Disclosure Package. As used herein, the Time of Sale means the time when sales of the International
Page 6 - Directors means the directors of the Company whose names are set out in the section headed Directors
Page 7 - Listing Date means the first day on which the Shares commence trading on the SEHK (which is expected
Page 8 - RMB or Renminbi means renminbi, the lawful currency of the PRC;
Page 9 - N/A
Page 10 - Reallocated Shares ), the number of Firm Shares available under the International Offering will be c
Page 11 - Unsold Shares ) to the International Offering to one or more of the International Underwriters in su
Page 12 - Stabilization Manager ) and may (but shall not be obliged to, and not as agent of the Company), to t
Page 13 - N/A
Page 14 - Closing Location ). A meeting will be held at the Closing Location at 4:00 p.m., Hong Kong time, on
Page 15 - N/A
Page 16 - Listing Rules ) and/or any other applicable Law, including to disclose by way of announcement or oth
Page 17 - N/A
Page 18 - Renewal Deadline ) of the initial effective date of the U.S. Registration Statement, any of the Offe
Page 19 - Six-Month Period ), the Company hereby undertakes to each of the Joint Global Coordinators, the Join
Page 20 - License ); provided, however, that the License shall be used solely for the purpose described above,
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - M A Rules ) and any official clarifications, guidance, interpretations or implementation rules in co
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - New York Court ), (ii) waives, to the fullest extent it may effectively do so, any objection which i
Page 38 - Bail-In Legislation means in relation to a member state of the European Economic Area which has impl
Page 39 - BRRD Counterparty means any party to this Agreement to whom the BRRD Party owes a BRRD Liability und
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - [Signature page to IUA]
Page 44 - [Signature page to IUA]
Page 45 - [Signature page to IUA]
Page 46 - [Signature page to IUA]
Page 47 - [Signature page to IUA]
Page 48 - [Signature page to IUA]
Page 49 - [Signature page to IUA]
Page 50 - [Signature page to IUA]
Page 51 - SCHEDULE I
Page 52 - SCHEDULE I
Page 53 - SCHEDULE II
Page 54 - SCHEDULE III
Page 55 - N/A
Page 56 - 2. The Company and the Group
Page 57 - PRC Overseas Investment and Listing Regulations ), including without limitation, requesting each sha
Page 58 - 3. Offer Shares
Page 59 - 4. This Agreement and Operative Documents
Page 60 - FINRA ) of the underwriting terms and arrangements, (B) such consents, approvals, authorizations, or
Page 61 - 6. Accounts and other financial information
Page 62 - US GAAP ) applied on a consistent basis throughout the periods presented (other than as described th
Page 63 - Critical Accounting Policies ); (B) judgments and uncertainties affecting the application of Critica
Page 64 - Off-balance Sheet Arrangements ) that are reasonably likely to have a material effect on the liquidi
Page 65 - 8. Subsequent events
Page 66 - Intellectual Property ) that are necessary or used in any material respect to conduct their business
Page 67 - FDA ), the European Medicines Agency ( EMA ), the China Drug Administration ( CDA ) or any comparabl
Page 68 - Applicable Laws ); (B) have not received any FDA Form 483, notice of adverse finding, warning letter
Page 69 - Information Technology ) comprise all of the information technology systems and related rights neces
Page 70 - 10. Compliance with employment and labor Laws
Page 71 - Hazardous Materials means any material (including, without limitation, pollutants, contaminants, haz
Page 72 - Sarbanes-Oxley Act ) and the rules and regulations promulgated thereunder; the Company has given due
Page 73 - disclosure and corporate governance controls and procedures means controls and other procedures that
Page 74 - UNSC ), the European Union, Her Majesty s Treasury ( HMT ), or other relevant sanctions authority (c
Page 75 - 16. Provision of information to research analysts
Page 76 - 19. Dividends
Page 77 - 20. Litigation and other proceedings
Page 78 - 22. Choice of law and dispute resolution
Page 79 - 24. United States aspects
Page 80 - Form 8-A Registration Statement ); and the Form 8-A Registration Statement when it became effective
Page 81 - 25. Cornerstone Investment
Page 82 - EXHIBIT A
Page 83 - EXHIBIT B
Page 84 - EXHIBIT C
Page 85 - EXHIBIT D
Page 86 - EXHIBIT E
Page 87 - N/A
Page 88 - N/A
Page 89 - N/A
Page 90 - [Signature Page to Lock-up Agreement]
Subdocument 3 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - 2. Assumptions
Page 3 - 5. Consent
Subdocument 4 - EX-8.2 - EX-8.2
Page 1 - Exhibit 8.2
Page 2 - Documents ).
Page 3 - I. Opinions
Page 4 - N/A
Subdocument 5 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - About BeiGene